These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35358374)

  • 1. Coupling Lipid Nanoparticle Structure and Automated Single-Particle Composition Analysis to Design Phospholipase-Responsive Nanocarriers.
    Barriga HMG; Pence IJ; Holme MN; Doutch JJ; Penders J; Nele V; Thomas MR; Carroni M; Stevens MM
    Adv Mater; 2022 Jul; 34(26):e2200839. PubMed ID: 35358374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating the Structure and Gene Silencing Activity of Oligonucleotide-Loaded Lipid Nanoparticles Using Small-Angle X-ray Scattering.
    Hammel M; Fan Y; Sarode A; Byrnes AE; Zang N; Kou P; Nagapudi K; Leung D; Hoogenraad CC; Chen T; Yen CW; Hura GL
    ACS Nano; 2023 Jun; 17(12):11454-11465. PubMed ID: 37279108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the mechanism of action of DNA-loaded PEGylated lipid nanoparticles.
    Digiacomo L; Renzi S; Quagliarini E; Pozzi D; Amenitsch H; Ferri G; Pesce L; De Lorenzi V; Matteoli G; Cardarelli F; Caracciolo G
    Nanomedicine; 2023 Sep; 53():102697. PubMed ID: 37507061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery.
    Gindy ME; DiFelice K; Kumar V; Prud'homme RK; Celano R; Haas RM; Smith JS; Boardman D
    Langmuir; 2014 Apr; 30(16):4613-22. PubMed ID: 24684657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations.
    Pratsinis A; Fan Y; Portmann M; Hammel M; Kou P; Sarode A; Ringler P; Kovacik L; Lauer ME; Lamerz J; Hura GL; Yen CW; Keller M
    Int J Pharm; 2023 Apr; 637():122874. PubMed ID: 36948476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.
    Bunjes H; Unruh T
    Adv Drug Deliv Rev; 2007 Jul; 59(6):379-402. PubMed ID: 17658653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
    Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
    Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA.
    Tajik-Ahmadabad B; Mechler A; Muir BW; McLean K; Hinton TM; Separovic F; Polyzos A
    Chembiochem; 2017 May; 18(10):921-930. PubMed ID: 28233412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury.
    Waggoner LE; Miyasaki KF; Kwon EJ
    Biomater Sci; 2023 Jun; 11(12):4238-4253. PubMed ID: 36987922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
    Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB
    Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
    Tenchov R; Bird R; Curtze AE; Zhou Q
    ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy.
    Wilhelmy C; Keil IS; Uebbing L; Schroer MA; Franke D; Nawroth T; Barz M; Sahin U; Haas H; Diken M; Langguth P
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomistic Insights into Organization of RNA-Loaded Lipid Nanoparticles.
    Paloncýová M; Šrejber M; Čechová P; Kührová P; Zaoral F; Otyepka M
    J Phys Chem B; 2023 Feb; 127(5):1158-1166. PubMed ID: 36602349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs.
    Bogaert B; Sauvage F; Guagliardo R; Muntean C; Nguyen VP; Pottie E; Wels M; Minnaert AK; De Rycke R; Yang Q; Peer D; Sanders N; Remaut K; Paulus YM; Stove C; De Smedt SC; Raemdonck K
    J Control Release; 2022 Oct; 350():256-270. PubMed ID: 35963467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA-Lipid Complexes.
    Szebeni J; Kiss B; Bozó T; Turjeman K; Levi-Kalisman Y; Barenholz Y; Kellermayer M
    ACS Nano; 2023 Jul; 17(14):13147-13157. PubMed ID: 37417667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.